Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'22
No of Months
12
12
Operating Income
15.00
3.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
15.00
3.00
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
0.00
Raw Materials Consumed
10.00
4.00
Power & Fuel Cost
1.00
0.00
Employee Cost
9.00
0.00
Operating Expenses
1.00
0.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
0.00
0.00
Cost of Software developments
0.00
0.00
Miscellaneous Expenses
2.00
0.00
Expenses Capitalised
0.00
0.00
Total Expenditure
28.00
3.00
Operating Profit (PBDIT) excl Other Income
-13.00
0.00
Other Income
0.00
0.00
Operating Profit (PBDIT)
-12.00
0.00
Interest
1.00
0.00
Profit before Depriciation and Tax
-13.00
0.00
Depreciation
1.00
0.00
Profit Before Taxation & Exceptional Items
-15.00
0.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
-15.00
0.00
Provision for Tax
-3.00
0.00
Profit After Tax
-11.00
0.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
-9.00
-2.00
Profit Available for appropriations
-17.00
-2.00
Appropriations
-17.00
-2.00
Equity Dividend (%)
0.00%
0.00%
Earnings Per Share
-3.56
0.14
Profit And Loss Analysis Highlights
Compare Profit and Loss Results of Pharmaids Pharma
Figures in Rs cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
15.00
10,334.00
-10,319.00
-99.85%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
15.00
10,334.00
-10,319.00
-99.85%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-94.00
95.00
101.06%
Raw Materials Consumed
10.00
3,263.00
-3,253.00
-99.69%
Power & Fuel Cost
1.00
129.00
-128.00
-99.22%
Employee Cost
9.00
2,274.00
-2,265.00
-99.60%
Operating Expenses
1.00
210.00
-209.00
-99.52%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
928.00
-928.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
134.00
-132.00
-98.51%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
28.00
7,798.00
-7,770.00
-99.64%
Operating Profit (PBDIT) excl Other Income
-13.00
2,536.00
-2,549.00
-100.51%
Other Income
0.00
280.00
-280.00
-100.00%
Operating Profit (PBDIT)
-12.00
2,817.00
-2,829.00
-100.43%
Interest
1.00
35.00
-34.00
-97.14%
Profit before Depriciation and Tax
-13.00
2,782.00
-2,795.00
-100.47%
Depreciation
1.00
398.00
-397.00
-99.75%
Profit Before Taxation & Exceptional Items
-15.00
2,384.00
-2,399.00
-100.63%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-15.00
2,399.00
-2,414.00
-100.63%
Provision for Tax
-3.00
457.00
-460.00
-100.66%
Profit After Tax
-11.00
1,926.00
-1,937.00
-100.57%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-9.00
8,012.00
-8,021.00
-100.11%
Profit Available for appropriations
-17.00
9,925.00
-9,942.00
-100.17%
Appropriations
-17.00
9,925.00
-9,942.00
-100.17%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-3.56
47.75
-51.31
-107.46%
Profit and Loss - Net Sales
Analysis not available as Data has been published for only 1 period
Profit and Loss - Operating Profit (PBDIT)
Analysis not available as Data has been published for only 1 period
Profit and Loss - Interest
Analysis not available as Data has been published for only 1 period
Profit and Loss - Profit After Tax
Analysis not available as Data has been published for only 1 period